Abolis Biotechnologies is a series a startup based in France. 1 investor tracked.
Based in France, Abolis Biotechnologies is a startup. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
Abolis Biotechnologies develops microbial biotechnology solutions to produce high-value molecules for the food, cosmetic, and pharmaceutical industries. The company uses engineered microbial strains and bioprocesses to create sustainable alternatives to petrochemical and plant-based products.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.